n(6)-carboxymethyllysine has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulkadir, SA; Deaton, RJ; Helou, YB; Kajdacsy-Balla, A; Macias, V; Murphy, AB; Murray, M; Nonn, L; Sverdlov, M; Voisine, C; Wang, H; Zenner, ML | 1 |
| Bracken, B; Kasper, S; Wong, RM; Wu, T | 1 |
2 other study(ies) available for n(6)-carboxymethyllysine and Adenoma, Prostatic
| Article | Year |
|---|---|
Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.
Topics: Age Factors; Black or African American; Correlation of Data; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Warburg Effect, Oncologic; White People | 2022 |
Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression.
Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; F2-Isoprostanes; Follow-Up Studies; Humans; Kallikreins; Lysine; Male; Middle Aged; Oxidative Stress; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Risk Assessment; Watchful Waiting | 2020 |